UPDATE : Monday, September 7, 2020
Amgen Korea wins new indication for acute lymphoblastic leukemia drug
Amgen Korea has received an expanded indication for Blincyto, a treatment f...
by Lee Han-soo  |  2020-09-04 18:04
SCM Lifescience punished for delaying adverse reaction report
The Ministry of Food and Drug Safety said it imposed an administrative warn...
by Kim Chan-hyuk  |  2020-09-04 14:54
Iraq approves Hutox as 1st BTX product
Huons said that Iraqi health authorities have approved Hutox, its botulinum...
by Lee Han-soo  |  2020-09-04 14:16
Novavax releases encouraging phase-1 results on Covid-19 vaccine candidate
Novavax unveiled the successful results of the phase-1 clinical trial on a ...
by Kim Yun-mi  |  2020-09-03 14:50
Chong Kun Dang to conduct P2 trials of Covid-19 therapy in Russia
Chong Kun Dang's anticoagulant and acute pancreatitis treatment Nafabel...
by Shim Hyun-tai  |  2020-09-03 12:36
Daewoong to expand indication of Nabota in US
Daewoong Pharmaceutical said it would enter the treatment market for botuli...
by Lee Han-soo  |  2020-09-03 12:13
‘Reduced-dose prasugrel effective for ACS patients undergoing PCI’
The European Society of Cardiology recently announced the 2020 ESC guidelin...
by Kim Yun-mi  |  2020-09-02 16:33
Regulator OKs JW Pharma's rheumarthritis drug for treating giant cell arteries
JW Pharmaceutical said Tuesday that its rheumatoid arthritis drug, Actemra ...
by Shim Hyun-tai  |  2020-09-02 14:08
FDA grants priority review to Hanmi’s Oraxol
Hanmi said the U.S. Food and Drug Administration has approved the new drug ...
by Lee Han-soo  |  2020-09-02 13:06
MedPacto’s oncology pipeline for blood cancer wins EU patent
MedPacto said Tuesday that it has obtained a European patent for a pharmace...
by Shim Hyun-tai  |  2020-09-01 17:14
AZ requests court to nullify Dong-A ST’s avoidance of Forxiga patent
AstraZeneca filed a suit with the Patent Court to cancel the Intellectual P...
by Kim Yun-mi  |  2020-09-01 15:40
MSD’s antiviral Prevymis gains insurance coverage
MSD Korea said that the Ministry of Health and Welfare has granted insuranc...
by Shim Hyun-tai  |  2020-09-01 15:05
LG Chem, SK Bioscience end sales partnership with Daewoong
Two leading local pharmaceutical firms, LG Chem and SK Bioscience, have rec...
by Kim Chan-hyuk  |  2020-09-01 14:12
LSK Global PS to conduct P3 trial of Sinovac's Covid-19 vaccine candidate
LSK Global Pharma Services said that it would conduct the phase 3 clinical ...
by Lee Han-soo  |  2020-09-01 12:17
Doctors force drug sales reps to support ongoing strike
Physicians are asking pharmaceutical sales representatives to criticize the...
by Kim Yun-mi  |  2020-09-01 11:24
MSD Korea’s Keytruda wins 2 new indications for treating cancer
MSD Korea’s immunotherapy Keytruda (ingredient: pembrolizumab) obtained two...
by Shim Hyun-tai  |  2020-08-31 16:44
China gives nod to Huonland’s eye drop for allergic inflammation
Huonland, a joint venture between Huons and Beijing Northland, said Monday ...
by Shim Hyun-tai  |  2020-08-31 15:28
‘Korea should introduce indication-specific drug pricing’
“Korea must introduce a system to apply different prices for a drug’s multi...
by Kim Yun-mi  |  2020-08-31 15:28
Collaboration: One way to simplify complexities in drug development
The rapidly expanding global healthcare industry has created intensifying d...
by Lee Han-soo  |  2020-08-31 13:52
Takeda’s Alunbrig available as primary therapy for lung cancer
The Ministry of Food and Drug Safety has approved Takeda Korea’s Alunbrig (...
by Shim Hyun-tai  |  2020-08-28 15:52
Back to Top